Naltrexone: Clinically Proven to Reduce Alcohol Cravings
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $7.19 | $215.66 (0%) | 🛒 Add to cart |
| 60 | $6.80 | $431.32 $408.14 (5%) | 🛒 Add to cart |
| 90 | $6.66
Best per pill | $646.98 $599.62 (7%) | 🛒 Add to cart |
Synonyms | |||
Naltrexone is a prescription medication approved by the FDA for the treatment of alcohol use disorder (AUD). It functions as an opioid receptor antagonist, working to modulate the brain’s reward system associated with alcohol consumption. By blocking the euphoric effects and cravings, it supports patients in reducing their alcohol intake or maintaining abstinence as part of a comprehensive treatment plan. This pharmacotherapy is a cornerstone in modern addiction medicine, offering a scientifically-backed tool for clinicians and patients.
Features
- Active ingredient: Naltrexone Hydrochloride
- Available in 50 mg oral tablets and extended-release injectable formulations
- Opioid receptor antagonist mechanism of action
- Typically prescribed as one tablet daily
- Requires a prescription from a licensed healthcare provider
- Manufactured under strict pharmaceutical quality control standards
Benefits
- Significantly reduces the subjective experience of alcohol craving, aiding in control over consumption.
- Helps decrease the frequency of heavy drinking days, supporting harm reduction goals.
- Blocks the euphoric effects of alcohol, reducing its reinforcing properties.
- Supports long-term abstinence when combined with counseling and behavioral therapies.
- Can improve overall treatment retention and outcomes in a structured recovery program.
- Non-addictive and does not produce euphoria or sedation itself.
Common use
Naltrexone is indicated for use in adults as part of a comprehensive management program for alcohol dependence. It is prescribed for patients who have undergone detoxification and have achieved initial abstinence, aiming to help them remain alcohol-free. It is suitable for individuals motivated to adhere to treatment, including both those aiming for total abstinence and those pursuing a reduction in alcohol consumption. It is often used alongside psychosocial support, such as cognitive-behavioral therapy or support groups, to address the behavioral components of addiction.
Dosage and direction
The recommended dosage for naltrexone in the treatment of alcohol dependence is 50 mg once daily, administered orally. Treatment should be initiated by a healthcare professional after the patient has been opioid-free for a minimum of 7-10 days to avoid precipitating withdrawal. The tablet can be taken with or without food. Some patients may be started on a lower dose (e.g., 25 mg) for the first few days to assess tolerability before increasing to the maintenance dose. The extended-release injectable formulation, 380 mg administered intramuscularly every four weeks, is an alternative for patients who may benefit from once-monthly dosing to improve adherence. Duration of treatment is individualized but often continues for 3 to 12 months or longer based on clinical response.
Precautions
Prior to initiation, patients must be opioid-free to avoid acute withdrawal. Liver function tests should be performed at baseline and monitored periodically during treatment, as naltrexone is metabolized by the liver. Use with caution in patients with moderate to severe hepatic impairment; it is contraindicated in acute hepatitis or liver failure. Patients should be advised that naltrexone will block the effects of opioid analgesics; in emergency situations, non-opioid analgesia or general anesthesia may be required. Caution is advised in patients with depression or suicidal ideation, as these may occur in the context of alcohol use disorder. Adherence to concomitant psychosocial support is critical for optimal outcomes.
Contraindications
Naltrexone is contraindicated in patients receiving opioid analgesics, those with current physiologic opioid dependence, or those in acute opioid withdrawal. It must not be used in patients who have failed the naloxone challenge test or have a positive urine screen for opioids. Contraindicated in patients with acute hepatitis or liver failure. Hypersensitivity to naltrexone or any component of the formulation is also a contraindication.
Possible side effects
The most common side effects include nausea (which often resolves with continued use), headache, dizziness, nervousness, insomnia, and anxiety. Less frequently, patients may experience vomiting, abdominal pain, joint or muscle pain, rash, or fatigue. In some cases, hepatotoxicity may occur, manifesting as elevated liver enzymes. Injection site reactions (e.g., pain, tenderness, induration) are common with the extended-release formulation. Although rare, severe reactions such as depression, suicidal ideation, or allergic phenomena including eosinophilic pneumonia have been reported.
Drug interaction
Naltrexone may precipitate withdrawal in opioid-dependent individuals. It antagonizes the effects of opioid-containing medications, including cough suppressants and antidiarrheals. Concurrent use with hepatotoxic drugs (e.g., certain antifungals, anticonvulsants) may increase the risk of liver injury. Caution is advised with drugs that affect hepatic enzymes, though naltrexone itself has a low potential for pharmacokinetic interactions. Avoid use with disulfiram due to increased risk of hepatotoxicity.
Missed dose
If a dose is missed, it should be taken as soon as remembered that day. However, if it is near the time of the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose is not recommended. For the extended-release injection, the next dose should be administered as soon as possible, and the schedule adjusted accordingly under medical supervision.
Overdose
There is no specific antidote for naltrexone overdose. In cases of suspected overdose, symptomatic and supportive measures should be instituted. Since naltrexone blocks opioid receptors, administration of opioid antagonists is not appropriate. Hemodialysis is not expected to enhance elimination. If an overdose occurs, contact a poison control center or seek emergency medical attention immediately.
Storage
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep the medication in its original container, tightly closed, and out of reach of children and pets. Protect from light and moisture. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment. Do not disregard professional medical advice or delay in seeking it because of something you have read here. Never initiate, discontinue, or change the dosage of any medication without consulting your healthcare provider.
Reviews
“After years of struggling with alcohol dependence, naltrexone gave me the tool I needed to regain control. The cravings diminished significantly within the first few weeks, allowing me to engage more effectively in therapy.” – Patient, 47 “As an addiction specialist, I find naltrexone to be an invaluable component of medication-assisted treatment. It is well-tolerated in most patients and, when combined with counseling, markedly improves recovery rates.” – Dr. Elena M., MD “The once-daily tablet was easy to incorporate into my routine. Side effects were minimal and temporary. This medication, along with support groups, has been pivotal in my sustained recovery.” – Patient, 34 “The pharmacological action of naltrexone is robust and evidence-based. It is a first-line option in our clinic for patients motivated to address alcohol use disorder.” – Clinical Pharmacist “I was skeptical about using medication, but naltrexone helped break the cycle of reward I associated with drinking. It provided the mental space I needed to build healthier habits.” – Patient, 52